Noven regulatory update

The FDA approved NOVN's transdermal estrogen system for the treatment of moderate-to-severe menopausal symptoms. The product will be marketed exclusively in the U.S. by Ciba Pharmaceuticals under the trade name Vivelle. NOVN (Miami) will manufacture the product and receive royalties. ...